Objectives. Leigh syndrome is a progressive early onset neurodegenerative disease typically presenting with psychomotor regression, signs of brainstem and/or basal ganglia disease, lactic acidosis, and characteristic magnetic resonance imaging findings. At molecular level, deficiency of respiratory complexes and/or pyruvate dehydrogenase complex is usually observed. Nuclear gene SURF1 encodes an assembly factor for cytochrome c-oxidase complex of the respiratory chain and autosomal recessive mutations in SURF1 are one of the most frequent causes of cytochrome c-oxidase-related Leigh syndrome cases. Here, we aimed to elucidate the genetic basis of Leigh syndrome in three Slovak families.
Methods and results. Three probands presenting with Leigh syndrome were selected for DNA analysis. The first proband, presenting with atypical LS onset without abnormal basal ganglia magnetic resonance imaging findings, was analyzed with whole exome sequencing. In the two remaining probands, SURF1 was screened by Sanger sequencing. Four different heterozygous mutations were identified in SURF1: c.312_321delinsAT:p.(Pro104Profs*1), c.588+1G>A, c.823_833+7del:p. (?) and c.845_846del:p.(Ser282Cysfs*9). All the mutations are predicted to have a loss-of-function effect.
Conclusions. We identified disease-causing mutations in all three probands, which points to the important role of SURF1 gene in etiology of Leigh syndrome in Slovakia. Our data showed that patients with atypical Leigh syndrome phenotype without lesions in basal ganglia may benefit from the whole exome sequencing method. In the case of probands presenting the typical phenotype, Sanger sequencing of the SURF1 gene seems to be an effective method of DNA analysis.
If the inline PDF is not rendering correctly, you can download the PDF file here.
Chen L Cui Y Jiang D Ma CY Tse HF Hwu WL Lian Q. Management of Leigh syndrome: Current status and new insights. Clin Gen Epub ahead of print 2017.
Gerards M Sallevelt SC Smeets HJ. Leigh syndrome: Resolving the clinical and genetic heterogeneity paves the way for treatment options. Mol Genet Metab 117 300–312 2016.
Guo Y Ye F Sheng Q Clark T Samuels DC. Three-stage quality control strategies for DNA re-sequencing data. Brief Bioinform 15 879–889 2013.
Lake NJ Compton AG Rahman S Thorburn DR. Leigh syndrome: One disorder more than 75 monogenic causes. Ann Neurol 79 190–203 2016.
Lee IC El-Hattab AW Wang J Li FY Weng SW Craigen WJ Wong LJ. SURF1-associated Leigh syndrome: a case series and novel mutations. Hum Mutat 33 1192–1200 2012.
Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 14 216–221 1951.
Maalej M Kammoun T Alila-Fersi O Kharrat M Ammar M Felhi R Mkaouar-Rebai E Keskes L Hachicha M Fakhfakh F. Cytochrome C oxydase deficiency: SURF1 gene investigation in patients with Leigh syndrome. Biochem Biophys Res Commun 497 1043–1048 2018.
Martinelli D Catteruccia M Piemonte F Pastore A Tozzi G Dionisi-Vici C Pontrelli G Corsetti T Livadiotti S Kheifets V Hinman A Shrader WD Thoolen M Klein MB Bertini E Miller G. EPI-743 reverses the progression of the pediatric mitochondrial disease-genetically defined Leigh Syndrome. Mol Genet Metab 107 383–388 2012.
McLaren W Gil L Hunt SE Riat HS Ritchie GR Thormann A Flicek P Cunningham F. The Ensembl Variant Effect Predictor. Genome Biol 17 122 2016.
Paila U Chapman BA Kirchner R Quinlan AR. GEMINI: integrative exploration of genetic variation and genome annotations. PLoS Comput Biol 9 e1003153 2013.
Pecina P Capkova M Chowdhury SK Drahota Z Dubot A Vojtiskova A Hansikova H Houstkova H Zeman J Godinot C Houstek J. Functional alteration of cytochrome c oxidase by SURF1 mutations in Leigh syndrome. Biochim Biophys Acta 1639 53–63 2003.
Pequignot MO Desguerre I Dey R Tartari M Zeviani M Agostino A Benelli C Fouque F Prip-Buus C Marchant D Abitbol M Marsac C. New splicing-site mutations in the SURF1 gene in Leigh syndrome patients. J Biol Chem 276 15326–15329 2001.
Rahman S Blok RB Dahl HH Danks DM Kirby DM Chow CW Christodoulou J Thorburn DR. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 39 343–351 1996.
Skopkova M Hennig F Shin BS Turner CE Stanikova D Brennerova K Stanik J Fischer U Henden L Muller U Steinberger D Leshinsky-Silver E Bottani A Kurdiova T Ukropec J Nyitrayova O Kolnikova M Klimes I Borck G Bahlo M Haas SA Kim JR Lotspeich-Cole LE Gasperikova D Dever TE Kalscheuer VM. EIF2S3 Mutations Associated with Severe X-Linked Intellectual Disability Syndrome MEHMO. Hum Mutat 38 409–425 2017.
Sofou K de Coo IFM Ostergaard E Isohanni P Naess K De Meirleir L Tzoulis C Uusimaa J Lonnqvist T Bindoff LA Tulinius M Darin N. Phenotype-genotype correlations in Leigh syndrome: new insights from a multicentre study of 96 patients. J Med Genet 55 21–27 2018.
Tan A Abecasis GR Kang HM. Unified representation of genetic variants. Bioinformatics 31 2202–2204 2015.
Tay SK Sacconi S Akman HO Morales JF Morales A De Vivo DC Shanske S Bonilla E DiMauro S. Unusual clinical presentations in four cases of Leigh disease cytochrome C oxidase deficiency and SURF1 gene mutations. J Child Neurol 20 670–674 2005.
Tiranti V Hoertnagel K Carrozzo R Galimberti C Munaro M Granatiero M Zelante L Gasparini P Marzella R Rocchi M Bayona-Bafaluy MP Enriquez JA Uziel G Bertini E Dionisi-Vici C Franco B Meitinger T Zeviani M. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 63 1609–1621 1998.
Wang J Raskin L Samuels DC Shyr Y Guo Y. Genome measures used for quality control are dependent on gene function and ancestry. Bioinformatics 31 318–323 2015.
Williams SL Taanman JW Hansikova H Houstkova H Chowdhury S Zeman J Houstek J. A novel mutation in SURF1 causes skipping of exon 8 in a patient with cytochrome c oxidase-deficient Leigh syndrome and hypertrichosis. Mol Genet Metab 73 340–343 2001.